No, One in Eight Americans Are Not Currently on Ozempic — Here's Where That Number Actually Comes From
“Approximately one in eight US adults are currently using GLP-1 medications like Ozempic, Wegovy, and Zepbound”
The argument in brief
A widely repeated claim says roughly one in eight US adults are currently using GLP-1 drugs like Ozempic or Wegovy. That's false. Multiple data sources put current use at 4–6% of adults — about half the claimed figure. The confusion traces back to a real survey, but one that measured people who had ever tried these drugs, not those actively taking them today.
Data: KFF Health Tracking Poll, June 2024
Why it spread
GLP-1 drugs are one of the biggest health stories in years, and people are primed to believe the transformation is massive and immediate. A figure like 'one in eight' feels like proof of a revolution already underway. The original survey data was real — it just measured something different than how it was reported, and in a fast-moving news environment, that nuance got lost almost immediately.
You've probably seen the headlines: GLP-1 drugs are everywhere, one in eight Americans are on them, the country is being transformed. The first two parts are debatable. The third is simply wrong. The 'one in eight' figure does not describe how many people are currently using these medications — it describes how many have ever tried them, and that distinction matters enormously.
The number most likely comes from a 2024 Gallup and West Health survey, which found that 1 in 8 adults had 'tried' GLP-1 medications at some point. That's a lifetime use figure. Somewhere between the press release and the news cycle, 'ever tried' quietly became 'currently using.' It's a small word swap with a big impact on meaning.
The actual current-use numbers are significantly lower. A June 2024 KFF Health Tracking Poll found that about 6% of US adults said they were currently taking a GLP-1 drug. IQVIA, which tracks real prescription data, estimated roughly 9 million Americans were actively filling these prescriptions monthly in 2023 — closer to 3–4% of adults. A Reuters analysis of insurance claims data landed at a similar figure: around 15 million active prescriptions, or about 4–5% of adults. Every independent data source tells the same story: current use is real and growing, but it's roughly half what the viral claim suggests.
To be fair, GLP-1 adoption is genuinely rapid by any historical standard, and the 'ever used' figure of around 12% is itself striking. These drugs are reshaping medicine and the pharmaceutical market in real ways. The problem isn't that the story is being told — it's that an inflated number is being used to tell it, which makes it harder to have an accurate conversation about healthcare access, costs, and what these drugs can realistically do at a population level.
This kind of error spreads because the inflated number fits a compelling narrative. GLP-1 drugs are a dominant cultural story right now, and a figure like 'one in eight' makes the shift feel more dramatic and historic. When a statistic confirms what we already believe — that something big is happening — we tend to pass it along without checking the fine print. Watch for the difference between 'ever used' and 'currently using' whenever you see drug adoption statistics. It's one of the most common ways health data gets quietly distorted.
Sources
- KFF Health Tracking Poll, 2024
As of June 2024, approximately 6% of US adults reported currently taking a GLP-1 medication, with 12% reporting they had ever used one. The 'one in eight' (12.5%) figure conflates current users with ever-users.
- Trilliant Health Report, 2024
Trilliant Health data showed GLP-1 prescriptions growing rapidly but current utilization rates among all US adults remained well below 10% as of 2024.
- Komodo Health / Reuters Analysis, 2024
Reuters analysis of claims data found roughly 15 million Americans (about 4-5% of adults) were actively prescribed GLP-1 drugs for diabetes or obesity as of early 2024.
- Gallup / West Health Survey, 2024
This survey found 1 in 8 adults had 'tried' GLP-1 medications — meaning ever used, not currently using. This is the likely origin of the misquoted statistic.
- IQVIA Institute for Human Data Science, 2024
IQVIA data showed approximately 9 million Americans were actively filling GLP-1 prescriptions monthly in 2023, representing roughly 3-4% of the adult population.
Related debunks
- UnverifiableCan't Confirm or Deny: Bill Ritter's Claim About His Cancer Treatment Is Unverifiable — Not False
- UnverifiableNo Evidence Bill Ritter Has Been Diagnosed With Alzheimer's — The Claim Is Unverified
- UnverifiableYes, Whey, Soy, and Pea Proteins Really Can Leave a Bad Aftertaste — And Science Explains Why